Efficacy, Safety and Pharmacokinetics Study of CPL500036 (PDE10A Inhibitor) in Patients With Schizophrenia

NCT05278156 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

189

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: CPL500036 - low dose
DRUG: CPL500036 - high dose
DRUG: Placebo

Sponsor

Celon Pharma SA

Collaborators

[object Object]